Kidney cancer patients need genetic testing.

For patients with renal cell carcinoma, high-throughput gene

sequencing (including hundreds of genes) is recommended to search for targeted drugs corresponding to

Currently, targeted drugs for the treatment of renal cell carcinoma are mainly used for adjuvant therapy after surgery or metastatic renal cell carcinoma. Targeted drugs commonly used include sunitinib, axitinib, sorafenib, botanib, lenvatinib, pezopanib, etc.